compounded semaglutide philadelphia Compound – Alliant LTC Pharmacy Heard the buzz about GLP-1

The glucagon-like peptide (GLP1) regulates food consumption and appetite, and its analogs, GLP-1 receptor agonists (GLP-1RAs), are used to treat type 2 diabetes, obesity, and metabolic syndrome

Overweight and obesity should be addressed to prevent CKM syndrome progression and to promote CKM syndrome regression

However, patients need to increase their resistance and weight-based workouts to combat muscle loss and increased appetite after coming off medication

doi: 10.1007/978-981-13-9589-5_3, 145 ZaarourR

Information about ongoing UK trials can be found via the NIHR Be Part of Research website (bepartofresearch.nihr.ac.uk) or the ClinicalTrials.gov database